Showing results (811-820 of 835) with videos related to

Sort By:
Pageof 84
The Journal of Pain|October 24, 2024
The use of abstract animations and a graphical body image for assessing pain outcomes among adults with sickle cell diseaseJulia A O'Brien, Charles R Jonassaint, Ektha Parchuri, et al.
Journal of Toxicology|August 23, 2021
Toxicity of Nanoparticles in Biomedical Application: NanotoxicologyChukwuebuka Egbuna, Vijaykumar K Parmar, Jaison Jeevanandam, et al.
Blood Advances|October 7, 2024
Digital cognitive behavioral therapy vs education for pain in adults with sickle cell diseaseCharles R Jonassaint, Christina M Lalama, C Patrick Carroll, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor ModelsCaitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Soft Matter|February 13, 2023
Steering self-organisation through confinementNuno A M Araújo, Liesbeth M C Janssen, Thomas Barois, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecovirusesTheocharis Tsoleridis, Chengcheng Fan, Emily J Park, et al.
Pneumonia (Nathan Qld.)|July 14, 2017
Pneumococcal conjugate vaccine implementation in middle-income countriesSerena Tricarico, Hannah C McNeil, David W Cleary, et al.
Food Science & Nutrition|July 17, 2023
Phytochemicals and bioactive compounds effective against acute myeloid leukemia: A systematic reviewChukwuebuka Egbuna, Kingsley C Patrick-Iwuanyanwu, Eugene N Onyeike, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brainAnn T Farrell, Julie Panepinto, C Patrick Carroll, et al.
Pageof 84